HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) has received an average recommendation of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, eleven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $110.3571.
HQY has been the subject of several recent research reports. Royal Bank Of Canada lowered their price objective on HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a research note on Wednesday, March 18th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research report on Wednesday, March 18th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a report on Thursday, January 22nd. Raymond James Financial set a $100.00 price target on shares of HealthEquity in a research report on Tuesday, February 17th. Finally, KeyCorp raised their price target on shares of HealthEquity from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, January 8th.
Read Our Latest Stock Report on HQY
Institutional Inflows and Outflows
HealthEquity Stock Performance
NASDAQ HQY opened at $84.67 on Tuesday. The company has a market cap of $7.15 billion, a price-to-earnings ratio of 34.42, a price-to-earnings-growth ratio of 1.54 and a beta of 0.26. HealthEquity has a twelve month low of $72.76 and a twelve month high of $116.65. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45. The business’s fifty day moving average is $79.90 and its 200 day moving average is $89.38.
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The business had revenue of $334.59 million during the quarter, compared to analysts’ expectations of $332.48 million. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The business’s revenue was up 7.3% on a year-over-year basis. As a group, sell-side analysts expect that HealthEquity will post 2.32 EPS for the current fiscal year.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
